Evolution, safety, and highly pathogenic influenza viruses

Science

Volumn 336, Issue 6088, 2012, Pages 1529-1531

  Lipsitch, Marc ^a   Plotkin, Joshua B ^b   Simonsen, Lone ^c   Bloom, Barry ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c GEORGE WASHINGTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAMANTANE; INFLUENZA VIRUS HEMAGGLUTININ; OSELTAMIVIR;

BIOSAFETY; DISEASE SPREAD; DISEASE TRANSMISSION; EVOLUTIONARY BIOLOGY; FITNESS; FUTURE PROSPECT; HEALTH RISK; INFLUENZA; LABORATORY METHOD; PATHOGENICITY; PHENOTYPE; PUBLIC HEALTH; UNCERTAINTY ANALYSIS;

ANTIVIRAL RESISTANCE; BIOLOGICAL ACCIDENT; BIOSAFETY; EVOLUTION; GENETIC DRIFT; HEALTH CARE PERSONNEL MANAGEMENT; HUMAN; INFECTION RISK; INFLUENZA; INFLUENZA VIRUS; INFLUENZA VIRUS A H3N2; INFLUENZA VIRUS A H5N1; LABORATORY TEST; NONHUMAN; NUCLEOTIDE SEQUENCE; OCCUPATIONAL SAFETY; PHENOTYPE; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; REVIEW; RISK BENEFIT ANALYSIS; SARS CORONAVIRUS; VIRUS MUTATION; VIRUS STRAIN; VIRUS TRANSMISSION; VIRUS VIRULENCE;

EID: 84862611097     PISSN: 00368075     EISSN: 10959203     Source Type: Journal    
DOI: 10.1126/science.1223204     Document Type: Review

References (29)

1. M. Imai et al., Nature; published online 2 May 2012. Updated online 22 May 2012. doi:10.1038/nature10831.
2. S. Herfst et al., Science 336, 1534 (2012).
3. U.S. Government Policy for Oversight of Life Sciences Dual Use Research of Concern, 29 March 2012; http://oba.od. nih.gov/oba/biosecurity/PDF/United- States-Government- Policy-for-Oversight-of-DURC-FINAL-version-032812.pdf.
4. US National Science Advisory Board for Biosafety, National Science Advisory Board for Biosecurity Findings and Recommendations, March 29-30, 2012; http://oba.od.nih.gov/oba/biosecurity/PDF/03302012-NSABB-Recommendations.pdf; (accessed 9 May 2012).
5. World Health Organization, Report on technical consultation on H5N1 research issues. www.who.int/ entity/influenza/human-animal-interface/mtg- report-h5n1.pdf; (accessed May 9, 2012).
6. C. Sweet, F. G. Hayden, K. J. Jakeman, S. Grambas, A. J. Hay, J. Infect. Dis. 164, 969 (1991).
7. F. G. Hayden et al., N. Engl. J. Med. 321, 1696 (1989).
8. R. A. Bright et al., Lancet 366, 1175 (2005).
9. L. Simonsen et al., Mol. Biol. Evol. 24, 1811 (2007).
10. M. Kiso et al., Lancet 364, 759 (2004).
11. M. L. Herlocher et al., J. Infect. Dis. 190, 1627 (2004).
12. P. Kramarz, D. Monnet, A. Nicoll, C. Yilmaz, B. Ciancio, Euro Surveill. 14, 19112 (2009).
13. J. D. Bloom, L. I. Gong, D. Baltimore, Science 328, 1272 (2010).
14. S. Kryazhimskiy, J. Dushoff, G. A. Bazykin, J. B. Plotkin, PLoS Genet. 7, e1001301 (2011).
15. N. M. Bouvier, S. Rahmat, N. Pica, J. Virol. (2012).
16. J. B. Plotkin, J. Dushoff, Proc. Natl. Acad. Sci. U.S.A. 100, 7152 (2003).
17. K. Koelle, S. Cobey, B. Grenfell, M. Pascual, Science 314, 1898 (2006).
18. F. Carrat, A. Flahault, Vaccine 25, 6852 (2007).
19. S. Herfst et al., J. Virol. 84, 3752 (2010).
20. J. Cohen, Science 335, 1155 (2012).
21. Case of SARS reported in a laboratory research worker in Taiwan. Euro Surveill. 7, 2347 (2003); available online at www.eurosurveillance.org/ ViewArticle.aspx? ArticleId=2347.
22. H. Pennington, Bull. World Health Organ. 81, 762 (2003).
23. UK Health and Safety Executive, Final report on potential breaches to biosecurity at the Pirbright site (London, 2007); www.hse.gov.uk/news/2007/ footandmouth.htm; (accessed 12 March 2012).
24. R. G. Webster, W. J. Bean, O. T. Gorman, T. M. Chambers, Y. Kawaoka, Microbiol. Rev. 56, 152 (1992).
25. U.S. Department of Health and Human Services, Biosafety in Microbiological and Biomedical Laboratories, 5th Edition, HHS publication no. (CDC) 21-1112 (2009).
26. U.S. Government Accountability Office, High-containment laboratories: National strategy for oversight is needed. Document GAO-09-574 (2009); www.gao.gov/new.items/ d09574.pdf.
27. A. K. Hottes, B. Rusek, F. Sharples, Committee on Anticipating Biosecurity Challenges of the Global Expansion of High Containment Biological Laboratories, National Academy of Sciences and National Research Council, Eds., Biosecurity Challenges of the Global Expansion of High-Containment Biological Laboratories, (National Academies Press, Washington, DC, 2012).
28. U.S. Department of Homeland Security, National Bio and Agro-Defense Facility, Final Environmental Impact Statement, Appendix B (2007); www.dhs.gov/xlibrary/ assets/nbaf-feis-appendix-b.pdf (accessed 13 May 2012).
29. Code of Federal Regulations, 42 CFR 73; www. selectagents.gov/resources/ 42 CFR 73.pdf.